Project/Area Number |
22590156
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Medical pharmacy
|
Research Institution | Kobe Pharmaceutical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
INUI Akio 鹿児島大学, 大学院・医歯学総合研究科, 教授 (80168418)
ASAKAWA Akihiro 鹿児島大学, 大学院・医歯学総合研究科, 准教授 (10452947)
KAKIHARA Hiroaki 京都大学, 大学院・薬学研究科, 教授 (20351314)
|
Research Collaborator |
ANDO Takashi 社会保険京都病院, 消化器内科
MITSUMOTO Yasuhide 社会保険京都病院, 消化器内科
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 消化器疾患 / 摂食調節ペプチド / ヘリコバクター・ピロリ / 臨床疫学研究 / インターフェロン / 摂量調節ペプチド |
Research Abstract |
Helicobacter pylori is a bacterium that has infected more than half of the Japanese population and is associated with chronic gastritis, peptic ulcer, and gastric cancer. We conducted a clinical study on the association between Helicobacter pylori infection and various feeding and metabolic regulating factors. The result raises the possibility that Helicobacter pylori infection affects the host’s nutritional status through changes in the plasma levels of ghrelin, which regulates feeding behavior, and adiponectin, which regulates metabolic status.
|